Dottorando, Università di Genova Italy
Veronica Torre is a PhD student in Experimental Medicine at the University of Genoa, specializing in pharmacology and toxicology. She has developed a multidisciplinary research approach through her extensive laboratory experiences, focusing on neuroscience, neuroinflammation, and synaptic pharmacology. Her academic journey is marked by outstanding performance, multilingual fluency, and international collaboration, including a visiting research stay at the University of Lille. Veronica is passionate about combining science with language proficiency and thrives in multicultural environments. Her dedication to research, problem-solving, and teamwork is evident in her scientific contributions, including peer-reviewed publications and international presentations. She actively contributes to the academic community through society memberships such as SIF, SINS, FENS, and SINUT, and is committed to exploring the intersections of neuroimmunology, pharmacological intervention, and natural compounds in disease models. Her work reflects perseverance, intellectual curiosity, and a deep commitment to advancing knowledge in experimental medicine.
Profile
Orcid
🎓 Education
Veronica Torre holds a Master’s degree in Medical and Pharmaceutical Biotechnology (110/110 cum laude) and a Bachelor’s degree in the same field from the University of Genoa. Her Master’s thesis, conducted at the San Martino Polyclinic Hospital, focused on the impact of pomegranate microdispersion on neuroinflammation in autoimmune encephalomyelitis, while her Bachelor’s thesis explored NK cell differentiation using EZH1/2 inhibitors. Currently pursuing a PhD in Experimental Medicine, her academic curriculum emphasizes pharmacology and toxicology. Veronica’s educational path is enriched by fluency in English, enabling her to undertake all higher studies in the language, and by international exposure during her visiting studentship at the University of Lille. Her academic distinction, coupled with hands-on training in clinical immunology and neuropharmacology, has laid a robust foundation for her scientific career. Her multidisciplinary coursework and research showcase a unique integration of neuroscience, pharmacology, and immunology in both theoretical and applied frameworks.
💼 Experience
Veronica Torre began her scientific journey in academic research at the University of Genoa, where she conducted lab-based studies involving in vitro and ex vivo experiments, pharmacological assays, and neurotransmitter analysis. She extended her expertise during a visiting PhD studentship at the University of Lille, focusing on glycobiology and neuroinflammatory pathways. She has worked in multiple laboratories, gaining hands-on experience in Western Blotting, ELISA, real-time PCR, flow cytometry, synaptosome and gliosome preparation, and animal model studies such as Experimental Autoimmune Encephalomyelitis. Her collaborative nature and adaptability enabled her to thrive in multidisciplinary environments, contributing significantly to both national and international projects. Her roles included conducting independent research, data analysis, and participating in peer-reviewed publications and oral/poster presentations. Fluent in multiple languages and proficient in scientific software like FlowJo and SigmaPlot, Veronica exemplifies a modern researcher combining technical skill, global perspective, and effective communication.
🏆 Awards and Honors
Veronica Torre graduated with top honors (110/110 cum laude) in both her Bachelor’s and Master’s degrees, earning thesis publication rights—a distinction reserved for exemplary academic performance. Her outstanding research on ellagic acid and neuroinflammation has been showcased at major scientific events, earning her invitations for oral presentations at nationally and internationally recognized congresses, including SINUT, SIF-IUPHAR, and SINS. Her research has led to co-authored publications in high-impact journals like Biomedicine & Pharmacotherapy and Current Neuropharmacology. She has also contributed to prominent symposiums like the FENS Forum and national scientific meetings, demonstrating leadership and communication skills. These recognitions reflect her innovative contributions to neuroscience and pharmacology, particularly in natural compound therapeutics. Veronica’s honors are testament to her dedication, intellectual rigor, and ability to translate laboratory insights into impactful scientific discourse. Her awards mark her as a rising scholar in neuroimmunopharmacology and experimental medicine.
🔬 Research Focus
Veronica Torre’s research centers on neuroimmunopharmacology, with a particular interest in the modulation of neuroinflammation and synaptic transmission using natural compounds like ellagic acid and urolithins. She investigates the role of neurotransmitter release mechanisms and presynaptic receptors—especially α2 adrenergic receptors—using models such as synaptosomes and gliosomes. Her work on Experimental Autoimmune Encephalomyelitis (EAE) in mice offers insights into multiple sclerosis pathology and the potential therapeutic effects of nutraceuticals. She is also involved in immunological studies on NK cell differentiation from CD34+ HSCs using epigenetic inhibitors. Her research combines preclinical models, in vitro analysis, and flow cytometry to assess immune and neural interactions. Veronica’s goal is to bridge systemic interventions with central nervous system outcomes, advancing therapeutic strategies in neurodegenerative and autoimmune disorders. Her interdisciplinary approach and translational focus reflect a strong commitment to developing novel, integrative treatments that target both neurological and immune components of disease.
✅ Conclusion
In conclusion, Veronica Torre is a highly promising candidate for the Best Researcher Award. Her strong scientific background, commendable publication record, and consistent participation in international research communities make her a deserving nominee. With continued growth in independent project leadership and global scientific communication, she is poised to make significant and lasting contributions to the fields of neuroscience and pharmacology.
Publication
Title: Presynaptic release-regulating α₂ receptors and Urolithins: A bridge between systemic EA administration and central health properties
Year: 2025
Authors:
Veronica Torre; Emanuela Marchese; Edward Willison; Martina Monaco; Matteo Bozzo; Giulia De Negri Atanasio; Alice Taddeucci; Hanna Trebesova; Francesca Rispo; Nicole Rosenwasser et al.
Link (DOI): https://doi.org/10.1016/j.biopha.2025.118187